{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T22:02:47Z","timestamp":1779746567729,"version":"3.53.1"},"reference-count":266,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012554","name":"Hubei Provincial Department of Education","doi-asserted-by":"publisher","award":["D20221503"],"award-info":[{"award-number":["D20221503"]}],"id":[{"id":"10.13039\/100012554","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["21807082"],"award-info":[{"award-number":["21807082"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177090"],"award-info":[{"award-number":["22177090"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019035","name":"Science and Technology Program of Hubei Province","doi-asserted-by":"publisher","award":["2024DJC062"],"award-info":[{"award-number":["2024DJC062"]}],"id":[{"id":"10.13039\/501100019035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118651","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:16:59Z","timestamp":1770337019000},"page":"118651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Recent advances in GABAA receptor targeting ligands"],"prefix":"10.1016","volume":"308","author":[{"given":"Yuanyan","family":"Zuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"S1","key":"10.1016\/j.ejmech.2026.118651_bib1","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1038\/sj.bjp.0706443","article-title":"GABA and glycine as neurotransmitters: a brief history","volume":"147","author":"Bowery","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0896-6273(94)90152-X","article-title":"How quickly can GABAA receptors open?","volume":"12","author":"Maconochie","year":"1994","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib3","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tins.2004.07.002","article-title":"Diversity of inhibitory neurotransmission through GABAA receptors","volume":"27","author":"Mody","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.ejmech.2026.118651_bib4","series-title":"Advances in Insect Physiology","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/B978-0-12-394389-7.00004-1","article-title":"Chapter four - \u03b3-aminobutyrate- and glutamate-gated chloride channels as targets of insecticides","volume":"vol. 44","author":"Ozoe","year":"2013"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00702-010-0381-z","article-title":"GABAA and GABAC receptor-mediated modulation of responses to color stimuli: electroretinographic study in the turtle Emys orbicularis","volume":"117","author":"Kupenova","year":"2010","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejmech.2026.118651_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1054-3589(10)58010-4","article-title":"GABAB receptors: physiological functions and mechanisms of diversity","volume":"58","author":"Pinard","year":"2010","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.4155\/fmc.10.286","article-title":"Medicinal chemistry of \u03c1 GABAC receptors","volume":"3","author":"Ng","year":"2011","journal-title":"Future Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nrd3502","article-title":"Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes","volume":"10","author":"Rudolph","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib9","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.tips.2009.12.005","article-title":"Binding, activation and modulation of Cys-loop receptors","volume":"31","author":"Miller","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0033583510000168","article-title":"The structural basis of function in Cys-loop receptors","volume":"43","author":"Thompson","year":"2010","journal-title":"Q. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib11","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1038\/s41467-020-19218-6","article-title":"The desensitization pathway of GABAA receptors, one subunit at a time","volume":"11","author":"Gielen","year":"2020","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib12","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.neuron.2016.03.032","article-title":"Emerging molecular mechanisms of signal transduction in pentameric ligand-gated ion channels","volume":"90","author":"Nemecz","year":"2016","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib13","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International union of pharmacology. LXX. Subtypes of \u03b3-aminobutyric acidA receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol. Rev."},{"issue":"17","key":"10.1016\/j.ejmech.2026.118651_bib14","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1523\/JNEUROSCI.16-17-05415.1996","article-title":"Stoichiometry of a recombinant GABAA receptor","volume":"16","author":"Chang","year":"1996","journal-title":"J. Neurosci."},{"issue":"15","key":"10.1016\/j.ejmech.2026.118651_bib15","doi-asserted-by":"crossref","first-page":"10100","DOI":"10.1074\/jbc.274.15.10100","article-title":"Stoichiometry of a ligand-gated ion channel determined by fluorescence energy transfer","volume":"274","author":"Farrar","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"39","key":"10.1016\/j.ejmech.2026.118651_bib16","doi-asserted-by":"crossref","first-page":"36275","DOI":"10.1074\/jbc.M105240200","article-title":"Subunit arrangement of \u03b3-aminobutyric acid type A receptors","volume":"276","author":"Baumann","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib17","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1523\/JNEUROSCI.17-08-02728.1997","article-title":"Stoichiometry and assembly of a recombinant GABAA receptor subtype","volume":"17","author":"Tretter","year":"1997","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0959-440X(94)90218-6","article-title":"Neurotransmitter-gated ion channels as unconventional allosteric proteins","volume":"4","author":"Galzi","year":"1994","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib19","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.neuron.2017.02.023","article-title":"GARLH family proteins stabilize GABAA receptors at synapses","volume":"93","author":"Yamasaki","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2026.118651_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.conb.2019.01.017","article-title":"Molecular constituents and localization of the ionotropic GABA receptor complex in vivo","volume":"57","author":"Tomita","year":"2019","journal-title":"Curr. Opin. Neurobiol."},{"issue":"6127","key":"10.1016\/j.ejmech.2026.118651_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/328221a0","article-title":"Sequence and functional expression of the GABAA receptor shows a ligand-gated receptor super-family","volume":"328","author":"Schofield","year":"1987","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0306-4522(03)00288-4","article-title":"Comparative modeling of GABAA receptors: limits, insights, future developments","volume":"119","author":"Ernst","year":"2003","journal-title":"Neuroscience"},{"issue":"7514","key":"10.1016\/j.ejmech.2026.118651_bib23","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature13293","article-title":"Crystal structure of a human GABAA receptor","volume":"512","author":"Miller","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib24","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/ALN.0000000000000588","article-title":"Structural comparisons of ligand-gated ion channels in open, closed, and desensitized states identify a novel propofol-binding site on mammalian \u03b3-aminobutyric acid type A receptors","volume":"122","author":"Franks","year":"2015","journal-title":"Anesthesiology"},{"issue":"39","key":"10.1016\/j.ejmech.2026.118651_bib25","doi-asserted-by":"crossref","first-page":"20440","DOI":"10.1074\/jbc.M115.698860","article-title":"Comparison of \u03b3-aminobutyric acid, type A (GABAA), receptor \u03b1\u03b2\u03b3 and \u03b1\u03b2\u03b4 expression using flow cytometry and electrophysiology","volume":"291","author":"Botzolakis","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib26","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nsmb.3484","article-title":"Structural basis for GABAA receptor potentiation by neurosteroids","volume":"24","author":"Miller","year":"2017","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"7904","key":"10.1016\/j.ejmech.2026.118651_bib27","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41586-022-04517-3","article-title":"Differential assembly diversifies GABAA receptor structures and signalling","volume":"604","author":"Sente","year":"2022","journal-title":"Nature"},{"issue":"7712","key":"10.1016\/j.ejmech.2026.118651_bib28","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41586-018-0255-3","article-title":"Structure of a human synaptic GABAA receptor","volume":"559","author":"Zhu","year":"2018","journal-title":"Nature"},{"issue":"7740","key":"10.1016\/j.ejmech.2026.118651_bib29","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-018-0833-4","article-title":"Cryo-EM structure of the human \u03b11\u03b23\u03b32 GABAA receptor in a lipid bilayer","volume":"565","author":"Laverty","year":"2019","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib30","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41422-018-0077-8","article-title":"Cryo-EM structure of the human \u03b15\u03b23 GABAA receptor","volume":"28","author":"Liu","year":"2018","journal-title":"Cell Res."},{"issue":"8050","key":"10.1016\/j.ejmech.2026.118651_bib31","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41586-024-08454-1","article-title":"Resolving native GABAA receptor structures from the human brain","volume":"638","author":"Zhou","year":"2025","journal-title":"Nature"},{"issue":"7740","key":"10.1016\/j.ejmech.2026.118651_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling mechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"issue":"7824","key":"10.1016\/j.ejmech.2026.118651_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2654-5","article-title":"Shared structural mechanisms of general anaesthetics and benzodiazepines","volume":"585","author":"Kim","year":"2020","journal-title":"Nature"},{"issue":"17","key":"10.1016\/j.ejmech.2026.118651_bib34","doi-asserted-by":"crossref","first-page":"4760","DOI":"10.1021\/acs.jafc.9b08189","article-title":"Potential of competitive antagonists of insect ionotropic \u03b3-aminobutyric acid receptors as insecticides","volume":"68","author":"Liu","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.apha.2017.03.003","article-title":"Chapter one - GABAA receptors and the diversity in their structure and pharmacology","volume":"79","author":"Chua","year":"2017","journal-title":"Adv. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1476-5381.2011.01779.x","article-title":"A novel GABAA receptor pharmacology: drugs interacting with the \u03b1+ \u03b2\u2010 interface","volume":"166","author":"Sieghart","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib37","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0028-3908(03)00299-5","article-title":"GABAA receptor modulation by the novel intravenous general anaesthetic E-6375","volume":"45","author":"Pau","year":"2003","journal-title":"Neuropharmacology"},{"issue":"27","key":"10.1016\/j.ejmech.2026.118651_bib38","doi-asserted-by":"crossref","first-page":"19343","DOI":"10.1074\/jbc.M113.479725","article-title":"Specificity of intersubunit general anesthetic-binding sites in the transmembrane domain of the human \u03b11\u03b23\u03b32 \u03b3-aminobutyric acid type A (GABAA) receptor","volume":"288","author":"Chiara","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nchembio.917","article-title":"Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands","volume":"8","author":"Richter","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118651_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phymed.2018.09.198","article-title":"Flavonoids isolated from Tibetan medicines, binding to GABAA receptor and the anticonvulsant activity","volume":"50","author":"Liu","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2026.118651_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112672","article-title":"Synthesis of 1,3,4-oxadiazole derivatives with anticonvulsant activity and their binding to the GABAA receptor","volume":"206","author":"Wang","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118651_bib42","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/13543776.2020.1746764","article-title":"GABAA receptor subtype modulators in medicinal chemistry: an updated patent review (2014-present)","volume":"30","author":"Crocetti","year":"2020","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088456","article-title":"Clobazam and its active metabolite N-desmethylclobazam display significantly greater affinities for \u03b12- versus \u03b11-GABAA-receptor complexes","volume":"9","author":"Jensen","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib44","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bmc.2014.12.016","article-title":"Novel agonists of benzodiazepine receptors: design, synthesis, binding assay and pharmacological evaluation of 1,2,4-triazolo[1,5-a]pyrimidinone and 3-amino-1,2,4-triazole derivatives","volume":"23","author":"Faizi","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib45","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1523\/JNEUROSCI.5012-10.2011","article-title":"The GABAA receptor \u03b1+\u03b2\u2212 interface: a novel target for subtype selective drugs","volume":"31","author":"Ramerstorfer","year":"2011","journal-title":"J. Neurosci."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib46","first-page":"5773","article-title":"Design and identification of a novel, functionally subtype selective GABAA positive allosteric modulator (PF-06372865)","volume":"62","author":"Owen","year":"2019","journal-title":"J. Med. Chem."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib47","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.3390\/molecules28124771","article-title":"Synthesis and receptor binding studies of \u03b15 GABAAR selective novel imidazodiazepines targeted for psychiatric and cognitive disorders","volume":"28","author":"Sharmin","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2026.118651_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejphar.2016.09.016","article-title":"Ester to amide substitution improves selectivity, efficacy and kinetic behavior of a benzodiazepine positive modulator of GABAA receptors containing the \u03b15 subunit","volume":"791","author":"Stameni\u0107","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib49","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s40263-019-00605-7","article-title":"Pharmacotherapy of postpartum depression: current approaches and novel drug development","volume":"33","author":"Frieder","year":"2019","journal-title":"CNS Drugs"},{"issue":"18","key":"10.1016\/j.ejmech.2026.118651_bib50","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1021\/acs.jmedchem.7b00846","article-title":"Neuroactive steroids. 2. 3\u03b1-Hydroxy-3\u03b2-methyl-21-(4-cyano-1 H -pyrazol-1\u2032-yl)-19-nor-5\u03b2-pregnan-20-one (SAGE-217): a clinical next generation neuroactive steroid positive allosteric modulator of the (\u03b3-aminobutyric acid)A receptor","volume":"60","author":"Martinez Botella","year":"2017","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neulet.2007.02.091","article-title":"Anaesthetic binding sites for etomidate and propofol on a GABAA receptor model","volume":"418","author":"Campagna-Slater","year":"2007","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib52","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/mol.115.099291","article-title":"A multifaceted GABAA receptor modulator: functional properties and mechanism of action of the sedative-hypnotic and recreational drug methaqualone (Quaalude)","volume":"88","author":"Hammer","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118651_bib53","doi-asserted-by":"crossref","first-page":"17398","DOI":"10.1074\/jbc.M110.108670","article-title":"Diversity of structure and function of \u03b11\u03b16\u03b23\u03b4 GABAA receptors","volume":"285","author":"Baur","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/acsptsci.1c00238","article-title":"Development of inhaled GABAA receptor modulators to improve airway function in bronchoconstrictive disorders","volume":"5","author":"Zahn","year":"2022","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib55","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1002\/cmdc.201402248","article-title":"5\u2010(Piperidin\u20104\u2010yl)\u20103\u2010Hydroxypyrazole: a novel scaffold for probing the orthosteric \u03b3\u2010aminobutyric acid type A receptor binding site","volume":"9","author":"Krall","year":"2014","journal-title":"ChemMedChem"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib56","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/emj.2010.095075","article-title":"Flumazenil use in benzodiazepine overdose in the UK: a retrospective survey of NPIS data","volume":"29","author":"Veiraiah","year":"2012","journal-title":"Emerg. Med. J."},{"key":"10.1016\/j.ejmech.2026.118651_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.106018","article-title":"The potentiating activity of benzodiazepine site of the GABA(A) receptor is inhibited by competitive antagonists of orthosteric site","volume":"188","author":"Solntseva","year":"2025","journal-title":"Neurochem. Int."},{"issue":"7981","key":"10.1016\/j.ejmech.2026.118651_bib58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41586-023-06556-w","article-title":"Cryo-EM structures reveal native GABAA receptor assemblies and pharmacology","volume":"622","author":"Sun","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118651_bib59","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/bs.apha.2014.10.002","article-title":"Allosteric modulation of GABAA receptors via multiple drug-binding sites","volume":"72","author":"Sieghart","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib60","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABAA receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib61","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/acschembio.8b00144","article-title":"Different benzodiazepines bind with distinct binding modes to GABAA receptors","volume":"13","author":"Elgarf","year":"2018","journal-title":"ACS Chem. Biol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib62","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1021\/cb500186a","article-title":"Relative positioning of classical benzodiazepines to the \u03b32 - subunit of GABAA receptors","volume":"9","author":"Middendorp","year":"2014","journal-title":"ACS Chem. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib63","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s002130050308","article-title":"Differences in enhancing effects of zolpidem and benzodiazepine drugs on recurrent inhibition in rat hippocampal slices","volume":"131","author":"Higashima","year":"1997","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib64","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1021\/ci900309s","article-title":"Combinatorial library enumeration and lead hopping using comparative interaction fingerprint analysis and classical 2D QSAR methods for seeking novel GABAA \u03b13 modulators","volume":"49","author":"Vijayan","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118651_bib65","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39383","article-title":"Cryo-EM structure of the benzodiazepine-sensitive \u03b11\u03b21\u03b32S tri-heteromeric GABAA receptor in complex with GABA","volume":"7","author":"Phulera","year":"2018","journal-title":"eLife"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib66","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1124\/mol.106.029595","article-title":"Structural determinants for high-affinity zolpidem binding to GABAA receptors","volume":"71","author":"Sancar","year":"2007","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib67","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1017\/S0033583524000179","article-title":"Molecular mechanisms of the GABA type A receptor function","volume":"58","author":"Micha\u0142owski","year":"2025","journal-title":"Q. Rev. Biophys."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib68","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.coph.2005.10.003","article-title":"GABA-based therapeutic approaches: GABAA receptor subtype functions","volume":"6","author":"Rudolph","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib69","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.tips.2018.03.006","article-title":"The benzodiazepine binding sites of GABAA receptors","volume":"39","author":"Sigel","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0304-4165(71)90142-5","article-title":"A versatile digital computer program for non-linear regression analysis","volume":"252","author":"Atkins","year":"1971","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"issue":"16","key":"10.1016\/j.ejmech.2026.118651_bib71","doi-asserted-by":"crossref","first-page":"17971","DOI":"10.1021\/acs.jmedchem.5c01770","article-title":"Discovery of novel antiepileptic agents targeting the \u03b11\u03b22\u03b32 GABAA receptor","volume":"68","author":"Gao","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104182","article-title":"Synthesis of 3,4-dihydroquinolin-2(1H)-one derivatives with anticonvulsant activity and their binding to the GABAA receptor","volume":"103","author":"Wang","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib73","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1021\/acsmedchemlett.0c00340","article-title":"Synthesis and biological evaluation of pyrroloindolines as positive allosteric modulators of the \u03b11\u03b22\u03b32 GABAA receptor","volume":"11","author":"Blom","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2026.118651_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104212","article-title":"Design, synthesis, and pharmacological evaluation of novel 1,2,4-triazol-3-amine derivatives as potential agonists of GABAA subtype receptors with anticonvulsant and hypnotic effects","volume":"104","author":"Jahani","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib75","doi-asserted-by":"crossref","first-page":"999","DOI":"10.3390\/molecules25040999","article-title":"Allosteric GABAA receptor modulators\u2014a review on the most recent heterocyclic chemotypes and their synthetic accessibility","volume":"25","author":"Vega Alanis","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.ejmech.2026.118651_bib76","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3390\/ijms20061438","article-title":"Synthesis of new GABAA receptor modulator with pyrazolo[1,5-a]quinazoline (PQ) scaffold","volume":"20","author":"Guerrini","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib77","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/bph.12151","article-title":"Identification of novel positive allosteric modulators and null modulators at the GABAA receptor \u03b1+\u03b2\u2212 interface","volume":"169","author":"Varagic","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.561834","article-title":"Demystifying the molecular basis of pyrazoloquinolinones recognition at the extracellular \u03b11+\/\u03b23- interface of the GABAA receptor by molecular modeling","volume":"11","author":"Singh","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib79","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.1016\/j.bja.2018.12.006","article-title":"Analgesic potential of PF-06372865, an \u03b12\/\u03b13\/\u03b15 subtype-selective GABAA partial agonist, in humans","volume":"123","author":"Van Amerongen","year":"2019","journal-title":"Br. J. Anaesth."},{"issue":"15","key":"10.1016\/j.ejmech.2026.118651_bib80","doi-asserted-by":"crossref","first-page":"e1786","DOI":"10.1212\/WNL.0000000000007271","article-title":"Photosensitive epilepsy: robust clinical efficacy of a selective GABA potentiator","volume":"92","author":"Gurrell","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib81","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ardp.200800213","article-title":"Synthesis of novel 2,5\u2010disubstituted 1,3,4\u2010thiadiazoles for their potential anticonvulsant activity: pharmacophoric model studies","volume":"342","author":"Rajak","year":"2009","journal-title":"Arch. Pharmazie"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118651_bib82","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J. Epidemiol. Community"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib83","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s40268-017-0207-7","article-title":"Benzodiazepines and Z-Drugs: an updated review of major adverse outcomes reported on in epidemiologic research","volume":"17","author":"Brandt","year":"2017","journal-title":"Drugs R&D"},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib84","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1021\/acschemneuro.5c00098","article-title":"Targeting GABAergic hypofunction associated with schizophrenia: identification of \u03b11\u03b22\u03b32GABAA receptor ligands with neuroprotective and antipsychotic properties","volume":"16","author":"Mordyl","year":"2025","journal-title":"ACS Chem. Neurosci."},{"issue":"16","key":"10.1016\/j.ejmech.2026.118651_bib85","doi-asserted-by":"crossref","first-page":"17538","DOI":"10.1021\/acs.jmedchem.5c01161","article-title":"Discovery of novel Isoindolin-1-one derivatives as GABAA receptors positive allosteric modulators with antiepileptic efficacy","volume":"68","author":"Tian","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1060949","article-title":"GABAA receptor subtypes and benzodiazepine use, misuse, and abuse","volume":"13","author":"Engin","year":"2023","journal-title":"Front. Psychiatr."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib87","doi-asserted-by":"crossref","first-page":"239","DOI":"10.14789\/jmj.JMJ24-0002-R","article-title":"Neurosteroid binding and actions on GABAA receptors","volume":"70","author":"Sugasawa","year":"2024","journal-title":"Juntendo Medical Journal"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib88","first-page":"1287","article-title":"The role of neurosteroids in the central nervous system function","volume":"62","author":"Basta-Kaim","year":"2005","journal-title":"Przegl. Lek."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118651_bib89","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.3390\/ijms21249391","article-title":"Neurosteroids and focal epileptic disorders","volume":"21","author":"L\u00e9vesque","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106525","article-title":"Positive association between dehydroepiandrosterone (DHEA) and gene expression of the gamma-aminobutyric acid (GABAA) receptor \u03b4 subunit","volume":"241","author":"Hamidovic","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib91","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/sj.bjp.0702597","article-title":"Bidirectional effects of the neuroactive steroid tetrahydrodeoxycorticosterone on GABA\u2010activated cl\u2212 currents in cultured rat hypothalamic neurons","volume":"127","author":"Wetzel","year":"1999","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib92","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0006-8993(89)90024-3","article-title":"Pregnenolone sulfate antagonizes GABAA receptor-mediated currents via a reduction of channel opening frequency","volume":"489","author":"Mienville","year":"1989","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib93","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1038\/s41467-023-40800-1","article-title":"Structural insights into opposing actions of neurosteroids on GABAA receptors","volume":"14","author":"Legesse","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib94","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41398-023-02514-2","article-title":"Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder","volume":"13","author":"Cutler","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib95","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.tips.2016.04.003","article-title":"Clinical potential of neurosteroids for CNS disorders","volume":"37","author":"Reddy","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib96","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1298359","article-title":"Zuranolone \u2013 synthetic neurosteroid in treatment of mental disorders: narrative review","volume":"14","author":"Marecki","year":"2023","journal-title":"Front. Psychiatr."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib97","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.3390\/ijms22115495","article-title":"The role of HPA axis and allopregnanolone on the neurobiology of major depressive disorders and PTSD","volume":"22","author":"Almeida","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib98","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/bs.apha.2014.10.006","article-title":"Inhibitory neurosteroids and the GABAA receptor","volume":"72","author":"Seljeset","year":"2015","journal-title":"Adv. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib99","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1038\/s41467-018-06361-4","article-title":"Structural basis of neurosteroid anesthetic action on GABAA receptors","volume":"9","author":"Chen","year":"2018","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib100","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1124\/jpet.115.229302","article-title":"Neurosteroid structure-activity relationships for functional activation of extrasynaptic \u03b4GABAA receptors","volume":"357","author":"Carver","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib101","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.neuron.2015.03.042","article-title":"The GABAA receptor as a therapeutic target for neurodevelopmental disorders","volume":"86","author":"Braat","year":"2015","journal-title":"Neuron"},{"issue":"49","key":"10.1016\/j.ejmech.2026.118651_bib102","doi-asserted-by":"crossref","first-page":"36352","DOI":"10.1039\/D4RA07074G","article-title":"Synthesis and evaluation of photoaffinity labeling reagents for identifying binding sites of sulfated neurosteroids on NMDA and GABAA receptors","volume":"14","author":"Qian","year":"2024","journal-title":"RSC Adv."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib103","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1002\/cne.23923","article-title":"The \u03b11, \u03b12, \u03b13, and \u03b32 subunits of GABAA receptors show characteristic spatial and temporal expression patterns in rhombencephalic structures during normal human brain development","volume":"524","author":"Stojanovic","year":"2016","journal-title":"J. Comp. Neurol."},{"issue":"10093","key":"10.1016\/j.ejmech.2026.118651_bib104","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(17)31264-3","article-title":"Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial","volume":"390","author":"Kanes","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib105","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/24750573.2017.1380352","article-title":"Brexanolone: an allosteric modulator of GABAA receptors in the rapid treatment of postpartum depression","volume":"27","author":"Kose","year":"2017","journal-title":"Psychiatry Clin. Psychopharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2020.112967","article-title":"GABA in the medial prefrontal cortex regulates anxiety-like behavior during the postpartum period","volume":"398","author":"Sabihi","year":"2021","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib107","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S1092852914000480","article-title":"The role of reproductive hormones in postpartum depression","volume":"20","author":"Schiller","year":"2015","journal-title":"CNS Spectr."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib108","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s40265-019-01121-0","article-title":"Brexanolone: first global approval","volume":"79","author":"Scott","year":"2019","journal-title":"Drugs"},{"issue":"10152","key":"10.1016\/j.ejmech.2026.118651_bib109","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0140-6736(18)31551-4","article-title":"Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials","volume":"392","author":"Meltzer-Brody","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2026.118651_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105754","article-title":"Medroxyprogesterone acetate positively modulates specific GABAA-receptors subtypes - affecting memory and cognition","volume":"141","author":"Das","year":"2022","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib111","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/19585969.2023.2262464","article-title":"Current pharmacotherapy approaches and novel GABAergic antidepressant development in postpartum depression","volume":"25","author":"Carlini","year":"2023","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ejmech.2026.118651_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105682","article-title":"Allopregnanolone in mood disorders: mechanism and therapeutic development","volume":"169","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib113","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1021\/acs.jmedchem.5b00032","article-title":"Neuroactive steroids. 1. Positive allosteric modulators of the (\u03b3-aminobutyric acid)A receptor: structure\u2013activity relationships of heterocyclic substitution at C-21","volume":"58","author":"Martinez Botella","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.699740","article-title":"Brexanolone, a GABAA modulator, in the treatment of postpartum depression in adults: a comprehensive review","volume":"12","author":"Edinoff","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib115","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/appi.ajp.20220785","article-title":"Zuranolone for the treatment of postpartum depression","volume":"180","author":"Deligiannidis","year":"2023","journal-title":"Am. J. Psychiatr."},{"issue":"13","key":"10.1016\/j.ejmech.2026.118651_bib116","doi-asserted-by":"crossref","first-page":"6545","DOI":"10.3390\/ijms26136545","article-title":"Neuroactive steroids as novel promising drugs in therapy of postpartum depression\u2014focus on zuranolone","volume":"26","author":"Zawilska","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108333","article-title":"Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator","volume":"181","author":"Althaus","year":"2020","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib118","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","article-title":"Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial","volume":"78","author":"Deligiannidis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib119","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acs.jmedchem.4c02881","article-title":"Design, synthesis, and pharmacological evaluation of nonsteroidal tricyclic ligands as modulators of GABAA receptors","volume":"68","author":"Xu","year":"2025","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuroscience.2024.06.002","article-title":"Forty years searching for neurosteroid binding sites on GABAA receptors","volume":"578","author":"Mortensen","year":"2025","journal-title":"Neuroscience"},{"issue":"Pt A","key":"10.1016\/j.ejmech.2026.118651_bib121","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.neuropharm.2016.10.010","article-title":"Endogenous and synthetic neuroactive steroids evoke sustained increases in the efficacy of GABAergic inhibition via a protein kinase C-dependent mechanism","volume":"113","author":"Modgil","year":"2017","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib122","article-title":"Design, synthesis, anticonvulsant evaluation, and molecular docking studies of new GABAA agonist derivatives","volume":"24","author":"Nassiri Koopaei","year":"2025","journal-title":"Iran. J. Pharm. Res. (IJPR)"},{"key":"10.1016\/j.ejmech.2026.118651_bib123","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bcp.2018.02.015","article-title":"Delineation of the functional properties and the mechanism of action of AA29504, an allosteric agonist and positive allosteric modulator of GABAA receptors","volume":"150","author":"Olander","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib124","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2017.11.006","article-title":"Functional properties and mechanism of action of PPTQ, an allosteric agonist and low nanomolar positive allosteric modulator at GABAA receptors","volume":"147","author":"Madjroh","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2024.108105","article-title":"The CryoEM structure of human serum albumin in complex with ligands","volume":"216","author":"Catalano","year":"2024","journal-title":"J. Struct. Biol."},{"issue":"16","key":"10.1016\/j.ejmech.2026.118651_bib126","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s40265-023-01953-x","article-title":"Zuranolone: first approval","volume":"83","author":"Heo","year":"2023","journal-title":"Drugs"},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib127","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1213\/ANE.0000000000001358","article-title":"Contrasting effects of the \u03b3-aminobutyric acid type A receptor \u03b23 subunit N265M mutation on loss of righting reflexes induced by etomidate and the novel anesthetic barbiturate R\u2013mTFD-MPAB","volume":"123","author":"Amlong","year":"2016","journal-title":"Anesth. Analg."},{"issue":"4-5","key":"10.1016\/j.ejmech.2026.118651_bib128","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neuropharm.2009.12.023","article-title":"Pharmacological characterization of a novel positive modulator at \u03b14\u03b23\u03b4-containing extrasynaptic GABAA receptors","volume":"58","author":"Hoestgaard-Jensen","year":"2010","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib129","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/sj.bjp.0701563","article-title":"The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study","volume":"122","author":"Pistis","year":"1997","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib130","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/bja\/aeh125","article-title":"The interaction of anaesthetic steroids with recombinant glycine and GABAA receptors","volume":"92","author":"Weir","year":"2004","journal-title":"Br. J. Anaesth."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118651_bib131","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1124\/mol.112.084558","article-title":"State-dependent etomidate occupancy of its allosteric agonist sites measured in a cysteine-substituted GABAA receptor","volume":"83","author":"Stewart","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib132","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.phrs.2017.12.031","article-title":"Comparison of \u03b1\u03b2\u03b4 and \u03b1\u03b2\u03b3 GABAA receptors: allosteric modulation and identification of subunit arrangement by site-selective general anesthetics","volume":"133","author":"Feng","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib133","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1111\/j.1471-4159.1993.tb03320.x","article-title":"Molecular determinants of general anesthetic action: role of GABAA receptor structure","volume":"60","author":"Lin","year":"1993","journal-title":"J. Neurochem."},{"issue":"20","key":"10.1016\/j.ejmech.2026.118651_bib134","doi-asserted-by":"crossref","first-page":"20982","DOI":"10.1074\/jbc.M400472200","article-title":"Gating allosterism at a single class of etomidate sites on \u03b11\u03b22\u03b32L GABAA receptors accounts for both direct activation and agonist modulation","volume":"279","author":"R\u00fcsch","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ejmech.2019.03.043","article-title":"GABA allosteric modulators: an overview of recent developments in non-benzodiazepine modulators","volume":"171","author":"Solomon","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.04.034","article-title":"Involvement of the GABAA receptor \u03b1 subunit in the mode of action of etifoxine","volume":"145","author":"Mattei","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib137","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/antiox13050585","article-title":"2-(4-Methylthiazol-5-yl) ethyl nitrate hydrochloride ameliorates cognitive impairment via modulation of oxidative stress and nuclear factor kappa B (NF-\u03baB) signaling pathway in chronic cerebral hypoperfusion-associated spontaneously hypertensive rats","volume":"13","author":"Li","year":"2024","journal-title":"Antioxidants"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib138","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004010051047","article-title":"Clomethiazole (ZENDRA, CMZ) improves hind limb motor function and reduces neuronal damage after severe spinal cord injury in rat","volume":"98","author":"Farooque","year":"1999","journal-title":"Acta Neuropathol."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib139","doi-asserted-by":"crossref","first-page":"8025","DOI":"10.1021\/acs.jmedchem.4c02514","article-title":"Novel spiro-barbiturates can reverse the action of general anesthetics on the GABAAR","volume":"68","author":"Koinas","year":"2025","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib140","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/14795","article-title":"Supersensitivity to allosteric GABAA receptor modulators and alcohol in mice lacking PKC\u03b5","volume":"2","author":"Hodge","year":"1999","journal-title":"Nat. Neurosci."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118651_bib141","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s40263-015-0257-8","article-title":"Alzheimer's disease: lessons learned from amyloidocentric clinical trials","volume":"29","author":"Soejitno","year":"2015","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118651_bib142","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/nrd2959","article-title":"Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies","volume":"8","author":"Brunden","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118651_bib143","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1021\/acsmedchemlett.5c00499","article-title":"Spiro hydantoins can reverse the action of positive allosteric modulators on GABAARs","volume":"16","author":"Koinas","year":"2025","journal-title":"ACS Med. Chem. Lett."},{"issue":"suppl_1","key":"10.1016\/j.ejmech.2026.118651_bib144","doi-asserted-by":"crossref","first-page":"i167","DOI":"10.1093\/bja\/aex369","article-title":"Role of GABAA receptor subtypes in the behavioural effects of intravenous general anaesthetics","volume":"119","author":"Weir","year":"2017","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejmech.2026.118651_bib145","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1272534","article-title":"Phenols and GABAA receptors: from structure and molecular mechanisms action to neuropsychiatric sequelae","volume":"15","author":"Menzikov","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172496","article-title":"Natural product incarvillateine aggravates epileptic seizures by inhibiting GABAA currents","volume":"858","author":"Bian","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114993","article-title":"(+)-Catharanthine potentiates the GABAA receptor by binding to a transmembrane site at the \u03b2(+)\/\u03b1(-) interface near the TM2-TM3 loop","volume":"199","author":"Arias","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib148","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4314\/bcse.v28i3.12","article-title":"New spiro (thio) barbiturates based on cyclohexanone and bicyclo [3.1.1]heptan-6-one by nonconcerted [1+5] cycloaddition reaction and their conformational structures","volume":"28","author":"Pesyan N","year":"2014","journal-title":"Bull. Chem. Soc. Ethiop."},{"key":"10.1016\/j.ejmech.2026.118651_bib149","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3389\/fnins.2020.00660","article-title":"GABAergic inhibitory interneuron deficits in alzheimer's disease: implications for treatment","volume":"14","author":"Xu","year":"2020","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib150","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1074\/jbc.M806484200","article-title":"Unanticipated structural and functional properties of \u03b4-Subunit-containing GABAA receptors","volume":"284","author":"Kaur","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"9-10","key":"10.1016\/j.ejmech.2026.118651_bib151","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S0028-3908(96)00076-7","article-title":"The cerebellum: a model system for studying GABAA receptor diversity","volume":"35","author":"Wisden","year":"1996","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib152","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1523\/JNEUROSCI.17-04-01350.1997","article-title":"Ligand-gated ion channel subunit partnerships: GABAA receptor \u03b16 subunit gene inactivation inhibits \u03b4 subunit expression","volume":"17","author":"Jones","year":"1997","journal-title":"J. Neurosci."},{"issue":"41","key":"10.1016\/j.ejmech.2026.118651_bib153","doi-asserted-by":"crossref","first-page":"12757","DOI":"10.1523\/JNEUROSCI.3340-09.2009","article-title":"Extrasynaptic GABAA receptors: form, pharmacology, and function","volume":"29","author":"Belelli","year":"2009","journal-title":"J. Neurosci."},{"issue":"24","key":"10.1016\/j.ejmech.2026.118651_bib154","doi-asserted-by":"crossref","first-page":"14439","DOI":"10.1073\/pnas.2435457100","article-title":"Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by \u03b4 subunit-containing GABAA receptors","volume":"100","author":"Stell","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib155","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1021\/acs.jmedchem.7b01484","article-title":"Structure\u2013function evaluation of imidazopyridine derivatives selective for \u03b4-Subunit-Containing \u03b3-aminobutyric acid type A (GABAA) receptors","volume":"61","author":"Yakoub","year":"2018","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib156","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.neuint.2006.06.001","article-title":"Allosteric modulation of [3H]EBOB binding to GABAA receptors by diflunisal analogues","volume":"49","author":"Uusi-Oukari","year":"2006","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib157","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0197-0186(98)00038-2","article-title":"Bimodal action of furosemide on convulsant [3H]EBOB binding to cerebellar and cortical gabaa receptors","volume":"33","author":"Maksay","year":"1998","journal-title":"Neurochem. Int."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib158","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2009.06387.x","article-title":"Structure of \u03b16\u03b23\u03b4 GABAA receptors and their lack of ethanol sensitivity","volume":"111","author":"Baur","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejmech.2026.118651_bib159","doi-asserted-by":"crossref","DOI":"10.1177\/24705470211020446","article-title":"Emerging therapeutics based on the amino acid neurotransmitter system: an update on the pharmaceutical pipeline for mood disorders","volume":"5","author":"Hecking","year":"2021","journal-title":"Chronic Stress"},{"issue":"46","key":"10.1016\/j.ejmech.2026.118651_bib160","doi-asserted-by":"crossref","first-page":"8419","DOI":"10.1039\/D5CC02037A","article-title":"Enhancing \u03c0\u2013\u03c0 stacking by a halogen substituent in a single-molecule junction","volume":"61","author":"Li","year":"2025","journal-title":"Chem. Commun."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib161","article-title":"Bromination: an alternative strategy for non-fullerene small molecule acceptors","volume":"7","author":"Wang","year":"2020","journal-title":"Adv. Sci."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib162","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1021\/cr950066q","article-title":"Bioisosterism: a rational approach in drug design","volume":"96","author":"Patani","year":"1996","journal-title":"Chem. Rev."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib163","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s00706-023-03063-6","article-title":"Novel pyrazolothienopyridinones as potential GABAA receptor modulators","volume":"154","author":"Vega Alanis","year":"2023","journal-title":"Monatsh. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib164","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1038\/s41598-017-05757-4","article-title":"Molecular tools for GABAA receptors: high affinity ligands for \u03b21-containing subtypes","volume":"7","author":"Simeone","year":"2017","journal-title":"Sci. Rep."},{"issue":"S3","key":"10.1016\/j.ejmech.2026.118651_bib165","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.21037\/atm.2019.06.23","article-title":"Cryo-electron microscopy reveals informative details of GABAA receptor structural pharmacology: implications for drug discovery","volume":"7","author":"Olsen","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ejmech.2026.118651_bib166","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ejmech.2019.07.008","article-title":"Variations on a scaffold - novel GABAA receptor modulators","volume":"180","author":"Iorio","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"35","key":"10.1016\/j.ejmech.2026.118651_bib167","doi-asserted-by":"crossref","first-page":"18474","DOI":"10.1074\/jbc.M116.738906","article-title":"Toward understanding functional properties and subunit arrangement of \u03b14\u03b22\u03b4 \u03b3-aminobutyric acid, type A (GABAA) receptors","volume":"291","author":"Wongsamitkul","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib168","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.nbd.2010.07.016","article-title":"Receptors with low affinity for neurosteroids and GABA contribute to tonic inhibition of granule cells in epileptic animals","volume":"40","author":"Rajasekaran","year":"2010","journal-title":"Neurobiol. Dis."},{"issue":"25","key":"10.1016\/j.ejmech.2026.118651_bib169","doi-asserted-by":"crossref","first-page":"15218","DOI":"10.1073\/pnas.2435171100","article-title":"Ethanol enhances \u03b14\u03b23\u03b4 and \u03b16\u03b23\u03b4 \u03b3-aminobutyric acid type A receptors at low concentrations known to affect humans","volume":"100","author":"Wallner","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118651_bib170","doi-asserted-by":"crossref","first-page":"4841","DOI":"10.1021\/bi100119t","article-title":"Dihydropyrimidinone positive modulation of \u03b4-subunit-containing \u03b3-aminobutyric acid type A receptors, including an epilepsy-linked mutant variant","volume":"49","author":"Lewis","year":"2010","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib171","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1016\/j.bmc.2006.01.033","article-title":"Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles","volume":"14","author":"Dawood","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib172","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1135\/cccc20000280","article-title":"Synthesis and analgesic activity of some 1-benzofurans, 1-benzothiophenes and indoles","volume":"65","author":"R\u00e1dl","year":"2000","journal-title":"Collect. Czech Chem. Commun."},{"issue":"10","key":"10.1016\/j.ejmech.2026.118651_bib173","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.cclet.2010.04.012","article-title":"A novel series of 2,5-disubstituted 1,3,4-thiadiazoles as potential anticonvulsant agent","volume":"21","author":"Rajak","year":"2010","journal-title":"Chin. Chem. Lett."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib174","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1016\/j.bmcl.2012.02.005","article-title":"Synthesis, resolution and anticonvulsant activity of chiral N-1\u2032-ethyl,N-3\u2032-(1-phenylethyl)-(R,S)-2\u2032H,3H,5\u2032H-spiro-(2-benzofuran-1,4\u2032-imidazolidine)-2\u2032,3,5\u2032-trione diastereomers","volume":"22","author":"Sadarangani","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib175","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4062\/biomolther.2015.030","article-title":"Neuroprotective and antioxidant effects of novel benzofuran-2-carboxamide derivatives","volume":"23","author":"Cho","year":"2015","journal-title":"Biomol. Ther."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib176","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ardp.201100108","article-title":"Design and synthesis of novel diphenyl oxalamide and diphenyl acetamide derivatives as anticonvulsants","volume":"345","author":"Nikalje","year":"2012","journal-title":"Arch. Pharmazie"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib177","first-page":"289","article-title":"New heterocyclic oxime ethers of 1-(benzofuran-2-yl)ethan-1-one and their antimicrobial activity","volume":"72","author":"Kosmalski","year":"2015","journal-title":"Acta Pol. Pharm."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib178","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00044-012-0017-y","article-title":"5-Phenyl-1-benzofuran-2-yl derivatives: synthesis, antimicrobial, and antioxidant activity","volume":"22","author":"Aswathanarayanappa","year":"2013","journal-title":"Med. Chem. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib179","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1177\/070674378803300206","article-title":"A sleep laboratory evaluation of the long-term efficacy of zopiclone","volume":"33","author":"Fleming","year":"1988","journal-title":"Can. J. Psychiatr."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib180","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/acph-2016-0023","article-title":"Design, synthesis and evaluation of benzofuran-acetamide scaffold as potential anticonvulsant agent","volume":"66","author":"Shakya","year":"2016","journal-title":"Acta Pharm."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib181","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1016\/j.bmcl.2012.02.094","article-title":"Design, synthesis and cytotoxic activities of novel hybrid compounds between 2-phenylbenzofuran and imidazole","volume":"22","author":"Yang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib182","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s11030-020-10068-4","article-title":"Rational approaches for the design of various GABA modulators and their clinical progression","volume":"25","author":"Bhagat","year":"2021","journal-title":"Mol. Divers."},{"issue":"Pt A","key":"10.1016\/j.ejmech.2026.118651_bib183","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuropharm.2017.07.030","article-title":"Impact on GABA systems in monogenetic developmental CNS disorders: clues to symptomatic treatment","volume":"136","author":"Benke","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2026.118651_bib184","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.599812","article-title":"The Z-drugs zolpidem, zaleplon, and eszopiclone have varying actions on human GABAA receptors containing \u03b31, \u03b32, and \u03b33 subunits","volume":"14","author":"Richter","year":"2020","journal-title":"Front. Neurosci."},{"issue":"suppl_1","key":"10.1016\/j.ejmech.2026.118651_bib185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/sleep\/10.suppl_1.73","article-title":"Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia","volume":"10","author":"Klimm","year":"1987","journal-title":"Sleep"},{"key":"10.1016\/j.ejmech.2026.118651_bib186","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1114350","article-title":"Understanding the function of the GABAergic system and its potential role in rheumatoid arthritis","volume":"14","author":"Shan","year":"2023","journal-title":"Front. Immunol."},{"issue":"16","key":"10.1016\/j.ejmech.2026.118651_bib187","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1073\/pnas.94.16.8824","article-title":"A point mutation in the \u03b32 subunit of \u03b3-aminobutyric acid type A receptors results in altered benzodiazepine binding site specificity","volume":"94","author":"Buhr","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib188","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1393337","article-title":"Current evidence and future perspectives in the exploration of sleep-related eating disorder\u2013a systematic literature review","volume":"15","author":"Vasiliu","year":"2024","journal-title":"Front. Psychiatr."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib189","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/biom13020197","article-title":"GABAA alpha 2\/3 but not alpha 1 receptor subunit ligand inhibits harmaline and pimozide-induced tremor in rats","volume":"13","author":"Kosmowska","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib190","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1038\/s41467-022-32212-4","article-title":"Structural and dynamic mechanisms of GABAA receptor modulators with opposing activities","volume":"13","author":"Zhu","year":"2022","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib191","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13019","article-title":"Development of neuroactive steroids for the treatment of postpartum depression","volume":"34","author":"Gunduz\u2010Bruce","year":"2022","journal-title":"J. Neuroendocrinol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib192","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1165\/rcmb.2022-0084OC","article-title":"Imidazobenzodiazepine PI320 relaxes mouse peripheral airways by inhibiting calcium mobilization","volume":"67","author":"Perez-Zoghbi","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118651_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108759","article-title":"Peripheral GABAA receptors - physiological relevance and therapeutic implications","volume":"266","author":"Gaji\u0107 Boji\u0107","year":"2025","journal-title":"Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib194","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1172\/JCI86812","article-title":"Local GABAergic signaling within sensory ganglia controls peripheral nociceptive transmission","volume":"127","author":"Du","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118651_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105217","article-title":"GABA-mediated inhibition of human CD4+ T cell functions is enhanced by insulin but impaired by high glucose levels","volume":"105","author":"Jin","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2026.118651_bib196","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1016\/j.euroneuro.2019.09.268","article-title":"225 Effect of MP-III-022, positive modulator of alpha 5 containing GABAA receptors, on learning and memory","volume":"29","author":"Santrac","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib197","doi-asserted-by":"crossref","first-page":"L406","DOI":"10.1152\/ajplung.00107.2017","article-title":"GABAA receptor \u03b14 -subunit knockout enhances lung inflammation and airway reactivity in a murine asthma model","volume":"313","author":"Yocum","year":"2017","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.ejmech.2026.118651_bib198","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ebiom.2018.03.019","article-title":"GABA regulates release of inflammatory cytokines from peripheral blood mononuclear cells and CD4+ T cells and is immunosuppressive in type 1 diabetes","volume":"30","author":"Bhandage","year":"2018","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib199","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/biomedicines11020254","article-title":"The GABA and GABA-receptor system in inflammation, anti-tumor immune responses, and COVID-19","volume":"11","author":"Tian","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/jpet.123.002070","article-title":"Antinociceptive effects of \u03b12\/\u03b13-Subtype-Selective GABAA receptor positive allosteric modulators KRM-II-81 and NS16085 in Male rats: behavioral specificity","volume":"391","author":"Lewter","year":"2024","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118651_bib201","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1451634","article-title":"The deuterated pyrazoloquinolinone targeting \u03b16 subunit-containing GABAA receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy","volume":"15","author":"Fan","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2026.118651_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2025.108449","article-title":"Development of novel pegylated imidazobenzodiazepines as inhaled asthma drug candidates","volume":"249","author":"Kowalczyk","year":"2025","journal-title":"Respir. Med."},{"key":"10.1016\/j.ejmech.2026.118651_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmgh.2025.101704","article-title":"Development of a novel benzodiazepine to delineate peripheral GABAA signaling mechanisms in visceral pain syndromes","author":"Poslusney","year":"2026","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib204","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1182\/blood.2024025369","article-title":"Cryo-EM structure of the human native plasma coagulation factor XIII complex","volume":"145","author":"Singh","year":"2025","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118651_bib205","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.str.2025.07.014","article-title":"Cryo-EM structure of the vault from human brain reveals symmetry mismatch at its caps","volume":"33","author":"L\u00f6vestam","year":"2025","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2026.118651_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2025.10.036","article-title":"A comparison of positive and negative allosteric modulators of \u03b15-containing GABAARs in the treatment of affective disease","author":"Troppoli","year":"2025","journal-title":"Biol. Psychiatry"},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib207","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/j.jtho.2025.09.005","article-title":"Even with CNS-penetrant TKIs, radiation therapy should be used before systemic therapy for CNS metastases","volume":"20","author":"Van Rossum","year":"2025","journal-title":"J. Thorac. Oncol."},{"issue":"23","key":"10.1016\/j.ejmech.2026.118651_bib208","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1200\/JCO.24.01061","article-title":"Leptomeningeal metastasis in the era of CNS-penetrant tyrosine kinase inhibitor therapy","volume":"42","author":"Jeng","year":"2024","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib209","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0269881120981390","article-title":"Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data","volume":"35","author":"Gallo","year":"2021","journal-title":"J. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib210","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1021\/jm049256w","article-title":"Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABAA antagonists: synthesis, pharmacology, and molecular modeling","volume":"48","author":"Fr\u00f8lund","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib211","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2014.12.001","article-title":"GABA and GABA receptors in the gastrointestinal tract: from motility to inflammation","volume":"93","author":"Auteri","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib212","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0014-2999(02)02271-9","article-title":"Activity of novel 4-PIOL analogues at human \u03b11\u03b22\u03b32S GABAA receptors\u2014correlation with hydrophobicity","volume":"451","author":"Mortensen","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib213","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01959034","article-title":"Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist","volume":"4","author":"Christensen","year":"1982","journal-title":"Pharm. Weekbl. - Sci. Ed."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib214","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1021\/jm020027o","article-title":"Novel class of potent 4-arylalkyl substituted 3-isoxazolol GABAA antagonists: synthesis, pharmacology, and molecular modeling","volume":"45","author":"Fr\u00f8lund","year":"2002","journal-title":"J. Med. Chem."},{"issue":"26","key":"10.1016\/j.ejmech.2026.118651_bib215","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1021\/jm000371q","article-title":"A novel class of potent 3-isoxazolol GABAA antagonists: design, synthesis, and pharmacology","volume":"43","author":"Fr\u00f8lund","year":"2000","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib216","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/prot.22975","article-title":"New insights into the GABAA receptor structure and orthosteric ligand binding: receptor modeling guided by experimental data","volume":"79","author":"Sander","year":"2011","journal-title":"Proteins: Struct., Funct., Bioinf."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib217","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1021\/jm070038n","article-title":"4-aryl-5-(4-piperidyl)-3-isoxazolol GABAA antagonists: synthesis, pharmacology, and structure\u2212activity relationships","volume":"50","author":"Fr\u00f8lund","year":"2007","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib218","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1021\/jm050987l","article-title":"Potent 4-arylalkyl-substituted 3-isothiazolol GABAA competitive\/noncompetitive antagonists: synthesis and pharmacology","volume":"49","author":"Krehan","year":"2006","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib219","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1080\/13880209.2022.2096076","article-title":"Sleep-promoting activity of lotus (Nelumbo nucifera) rhizome water extract via GABAA receptors","volume":"60","author":"Ahn","year":"2022","journal-title":"Pharm. Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib220","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1584\/jpestics.D22-007","article-title":"Structural insights into the interaction between gabazine (SR-95531) and Laodelphax striatellus GABA receptors","volume":"47","author":"Fujie","year":"2022","journal-title":"J. Pestic. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib221","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pestbp.2018.02.002","article-title":"Fluxametamide: a novel isoxazoline insecticide that acts via distinctive antagonism of insect ligand-gated chloride channels","volume":"151","author":"Asahi","year":"2018","journal-title":"Pestic. Biochem. Physiol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib222","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/1744-7917.12789","article-title":"Novel alternative splicing of GABA receptor RDL exon 9 from Laodelphax striatellus modulates agonist potency","volume":"28","author":"Jiang","year":"2021","journal-title":"Insect Sci."},{"issue":"14","key":"10.1016\/j.ejmech.2026.118651_bib223","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1016\/j.bmcl.2011.05.067","article-title":"Synthesis and evaluation of highly potent GABAA receptor antagonists based on gabazine (SR-95531)","volume":"21","author":"Iqbal","year":"2011","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"D1","key":"10.1016\/j.ejmech.2026.118651_bib224","doi-asserted-by":"crossref","first-page":"D1438","DOI":"10.1093\/nar\/gkad944","article-title":"The IUPHAR\/BPS Guide to PHARMACOLOGY in 2024","volume":"52","author":"Harding","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib225","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/s41467-025-56796-9","article-title":"Structures of TGF-\u03b2 with betaglycan and signaling receptors reveal mechanisms of complex assembly and signaling","volume":"16","author":"Wieteska","year":"2025","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib226","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.1021\/acs.jmedchem.5b02023","article-title":"Design, synthesis, and biological evaluation of indoline and indole derivatives as potent and selective \u03b11A-adrenoceptor antagonists","volume":"59","author":"Zhao","year":"2016","journal-title":"J. Med. Chem."},{"issue":"29","key":"10.1016\/j.ejmech.2026.118651_bib227","doi-asserted-by":"crossref","first-page":"11522","DOI":"10.1021\/jacs.9b02895","article-title":"Genetically targeted optical control of an endogenous G protein-coupled receptor","volume":"141","author":"Donthamsetti","year":"2019","journal-title":"J. Am. Chem. Soc."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib228","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1007\/s11094-024-03099-w","article-title":"Synthesis, characterization and biological evaluation of novel benzimidazole derivatives against Candida albicans","volume":"57","author":"Chauhan","year":"2024","journal-title":"Pharm. Chem. J."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib229","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/s41467-021-25633-0","article-title":"Structural determinants and regulation of spontaneous activity in GABAA receptors","volume":"12","author":"Sexton","year":"2021","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118651_bib230","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.tibs.2021.01.011","article-title":"Direct structural insights into GABAA receptor pharmacology","volume":"46","author":"Kim","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib231","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117908","article-title":"Recent developments in the synthesis of indolizines and their derivatives as compounds of interest in medicinal chemistry: a review","volume":"297","author":"Botezatu","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118651_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103668","article-title":"Recent advances in synthesis and medicinal chemistry of benzodiazepines","volume":"97","author":"Arora","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib233","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2008178118","article-title":"Modulation of \u03b11\u03b23\u03b32 GABAA receptors expressed in X. laevis oocytes using a propofol photoswitch tethered to the transmembrane helix","volume":"118","author":"Borghese","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib234","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.611953","article-title":"Structure-guided computational methods predict multiple distinct binding modes for pyrazoloquinolinones in GABAA receptors","volume":"14","author":"Fabjan","year":"2021","journal-title":"Front. Neurosci."},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib235","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.3390\/ijms26125731","article-title":"Genistein and vanadate differentially modulate cortical GABAA receptor\/ATPase activity and behavior in rats via a phenol-sensitive mechanism","volume":"26","author":"Menzikov","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib236","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/jpp\/rgae136","article-title":"Protein phosphatase 2A inhibitors: a possible pharmacotherapy for benzodiazepine dependence","volume":"77","author":"Kobayashi","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib237","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-2007-993761","article-title":"Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid","volume":"74","author":"Trauner","year":"2008","journal-title":"Planta Med."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib238","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3390\/biom13020341","article-title":"The mechanism of enantioselective neurosteroid actions on GABAA receptors","volume":"13","author":"Tateiwa","year":"2023","journal-title":"Biomolecules"},{"issue":"14","key":"10.1016\/j.ejmech.2026.118651_bib239","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1016\/j.cell.2022.06.025","article-title":"Structural mechanisms of GABAA receptor autoimmune encephalitis","volume":"185","author":"Noviello","year":"2022","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201210","article-title":"Expression and purification of a functional heteromeric GABAA receptor for structural studies","volume":"13","author":"Claxton","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib241","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1124\/mol.105.017236","article-title":"Pharmacological properties of GABAA receptors containing \u03b31 subunits","volume":"69","author":"Khom","year":"2006","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib242","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000157","article-title":"Multiple functional neurosteroid binding sites on GABAA receptors","volume":"17","author":"Chen","year":"2019","journal-title":"PLoS Biol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib243","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/sj.bjp.0704795","article-title":"Pharmacological characterization of a novel cell line expressing human \u03b14\u03b23\u03b4 GABAA receptors","volume":"136","author":"Brown","year":"2002","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib244","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1440-1681.2010.05374.x","article-title":"Agonist function of the recombinant \u03b14\u03b23\u03b4 GABAA receptor is dependent on the human and rat variants of the \u03b14-subunit","volume":"37","author":"Wang","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.ejmech.2026.118651_bib245","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuro.2023.01.012","article-title":"Simulating dynamic interaction between diazepam and ethanol targeting the GABAA receptor via in silico model","volume":"95","author":"Wang","year":"2023","journal-title":"Neurotoxicology"},{"issue":"12","key":"10.1016\/j.ejmech.2026.118651_bib246","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.3390\/biom12121784","article-title":"Benzodiazepine modulation of GABAA receptors: a mechanistic perspective","volume":"12","author":"Goldschen-Ohm","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2026.118651_bib247","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1083189","article-title":"Modulation of GABAA receptors and of GABAergic synapses by the natural alkaloid gelsemine","volume":"15","author":"Marileo","year":"2023","journal-title":"Front. Mol. Neurosci."},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib248","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.appet.2005.01.003","article-title":"Palatability-dependent appetite and benzodiazepines: new directions from the pharmacology of GABAA receptor subtypes","volume":"44","author":"Cooper","year":"2005","journal-title":"Appetite"},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib249","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.tips.2018.04.003","article-title":"An emerging circuit pharmacology of GABAA receptors","volume":"39","author":"Engin","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2026.118651_bib250","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fncel.2014.00300","article-title":"Diffusion dynamics of synaptic molecules during inhibitory postsynaptic plasticity","volume":"8","author":"Petrini","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"11","key":"10.1016\/j.ejmech.2026.118651_bib251","first-page":"873","article-title":"Understanding GABAA receptor pharmacology","volume":"22","author":"Crunkhorn","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"issue":"8","key":"10.1016\/j.ejmech.2026.118651_bib252","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1474-4422(18)30252-7","article-title":"Expanding role of GABAA receptors in generalised epilepsies","volume":"17","author":"Mefford","year":"2018","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib253","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/epi4.12982","article-title":"Functional analysis of epilepsy-associated GABAA receptor mutations using Caenorhabditis elegans","volume":"9","author":"Gadhia","year":"2024","journal-title":"Epilepsia Open"},{"issue":"10","key":"10.1016\/j.ejmech.2026.118651_bib254","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1815981","article-title":"Trial of SAGE-217 in patients with major depressive disorder","volume":"381","author":"Gunduz-Bruce","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118651_bib255","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.euroneuro.2018.11.1036","article-title":"SAGE-217 in major depressive disorder: a multicenter, randomized, double-blind, phase 2 placebo-controlled trial","volume":"29","author":"Gunduz-Bruce","year":"2019","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118651_bib256","doi-asserted-by":"crossref","first-page":"e669","DOI":"10.1097\/MJT.0000000000001810","article-title":"New insights into pharmacology of GABAA receptor alpha subunits\u2013selective modulators","volume":"31","author":"Moraru","year":"2024","journal-title":"Am. J. Therapeut."},{"issue":"7887","key":"10.1016\/j.ejmech.2026.118651_bib257","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/s41586-021-04077-y","article-title":"Structure, function and pharmacology of human itch receptor complexes","volume":"600","author":"Yang","year":"2021","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ejmech.2026.118651_bib258","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2174\/0115672026394052250808075022","article-title":"Future directions in anxiolytic therapy: a comprehensive review of novel targets and strategies","volume":"22","author":"Mahima","year":"2025","journal-title":"Curr. Neurovascular Res."},{"issue":"6","key":"10.1016\/j.ejmech.2026.118651_bib259","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1007\/s12035-017-0675-3","article-title":"Decreasing the expression of GABAA \u03b15 subunit-containing receptors partially improves cognitive, electrophysiological, and morphological hippocampal defects in the Ts65Dn model of Down syndrome","volume":"55","author":"Vidal","year":"2018","journal-title":"Mol. Neurobiol."},{"issue":"9","key":"10.1016\/j.ejmech.2026.118651_bib260","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.tips.2023.06.009","article-title":"GABAA receptors as targets for treating affective and cognitive symptoms of depression","volume":"44","author":"Luscher","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"issue":"22","key":"10.1016\/j.ejmech.2026.118651_bib261","doi-asserted-by":"crossref","first-page":"12456","DOI":"10.3390\/ijms222212456","article-title":"Significance of GABAA receptor for cognitive function and hippocampal pathology","volume":"22","author":"Sakimoto","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2026.118651_bib262","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2005.05.009","article-title":"GABAA receptor subtypes as targets for neuropsychiatric drug development","volume":"109","author":"Korpi","year":"2006","journal-title":"Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.ejmech.2026.118651_bib263","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/med.21959","article-title":"Targeting orexin receptors: recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders","volume":"43","author":"Bonifazi","year":"2023","journal-title":"Med. Res. Rev."},{"issue":"3","key":"10.1016\/j.ejmech.2026.118651_bib264","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/0269881119882803","article-title":"Evaluation of the anti-conflict, reinforcing, and sedative effects of YT-III-31, a ligand functionally selective for \u03b13 subunit-containing GABAA receptors","volume":"34","author":"Meng","year":"2020","journal-title":"J. Psychopharmacol."},{"issue":"7","key":"10.1016\/j.ejmech.2026.118651_bib265","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/s41594-019-0252-8","article-title":"Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs","volume":"26","author":"Roth","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"4","key":"10.1016\/j.ejmech.2026.118651_bib266","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/pr.117.014449","article-title":"International union of basic and clinical pharmacology. CVI: GABAA receptor Subtype- and function-selective ligands: key issues in translation to humans","volume":"70","author":"Sieghart","year":"2018","journal-title":"Pharmacol. Rev."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T21:12:53Z","timestamp":1779743573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":266,"alternative-id":["S0223523426000966"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118651","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in GABAA receptor targeting ligands","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118651"}}